101809-52-3

DIPROPIONYLLISOSPIRAMYCIN

2-Naphthalenesulfonamide,N-[4-[[2-(cyclohexylmethylamino)ethyl]methylamino]butyl]-,dihydrochloride

1,3-Propanediamine, N,N'-bis(2-aminoethyl)-N,N'-dimethyl-

1,2-Ethanediaminium, N,N,N',N'-tetrakis(2-hydroxypropyl)-N,N'-dimethyl-, N,N-diesters with coco fatty acids, dichlorides

2H-1,5-Benzodiazepin-2-one,1,3-dihydro-4-[3-(3-pyridinyl)phenyl]-8-(trifluoromethyl)-

2-Thiophenecarboxamide, N-[(2,4-dimethoxyphenyl)methyl]-3-methyl-

1H-Imidazole-5-carboxylic acid, 2-(4-chlorobenzoyl)-1-methyl-, methylester

2-Pentanone, 1-[3-(2-phenylethenyl)-1,4,2-dioxazol-5-yl]-

2H-1,4-Benzodiazepin-2-one,1,3-dihydro-1-methyl-3-[(1-methyl-1H-indol-3-yl)methyl]-5-(methylthio)-,(S)-

NRDC 139

(4-hydroxy-piperidin-1-yl)-acetic acid tert-butyl ester

2H-1,4-Benzothiazine-8-carboxamide,4-(4,5-dimethyl-2-thiazolyl)-3,4-dihydro-N-[4-(trifluoromethoxy)phenyl]-,1-oxide

d-Glucitol, 2-carboxyethyl ether, compds. with 2-ethyl-N,N-dimethyl-1-hexanamine

Carbamic acid, (3-butoxyphenyl)-,1-(methoxymethyl)-2-(4-methyl-1-piperazinyl)ethyl ester

Benzene, [(1-chloro-2-cyclohexylethenyl)sulfinyl]-

1H-Isoindol-1-one, 2-[4-(dimethylamino)phenyl]-2,3-dihydro-

2-Piperidinone,1-[(2R)-4-fluoro-2,3-dihydro-1H-inden-2-yl]-3-[[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]methylene]-, (3E)-

Cyclotrisiloxane,2-[2-(dichloromethylsilyl)ethyl]-2-methyl-4,4,6,6-tetraphenyl-

2,4(1H,3H)-Pyrimidinedione,6-[(3-ethyl-4-methylphenyl)amino]-3-[5-[4-(4-fluorophenyl)-3,6-dihydro-1(2H)-pyridinyl]pentyl]-

2-Naphthalenesulfonic acid, 1-hydroxy-4-[[4-(trifluoromethyl)phenyl]azo]-

2-Naphthalenesulfonic acid, 1-hydroxy-4-[(2-sulfophenyl)azo]-

2-Naphthalenesulfonic acid, 1-methyl-2-(phenylsulfonyl)hydrazide

9H-Purin-2-amine, 9-methyl-6-(phenylmethoxy)-

4-Quinolinamine,1,2,3,4-tetrahydro-2-methyl-1-(1-naphthalenylcarbonyl)-N-phenyl-

2-Furancarboxamide,tetrahydro-N-[4-[4-[(2-methylpropyl)amino]-5-phenylfuro[2,3-d]pyrimidin-6-yl]phenyl]-5-oxo-

2-Piperidinone,1-[(1R)-1-(4-fluorophenyl)-2-methoxy-1-methylethyl]-3-[[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]methylene]-, (3E)-

1,2,3,6-tetrahydro-4-(2-phenylethynyl)Pyridine

Benzenepropaneselenoamide

2H-Cyclopenta[b]furan, hexahydro-2-[1-(methylthio)ethyl]-

2H-1,5-Benzodiazepin-2-one,1,3-dihydro-4-[3-(4-pyridinyl)phenyl]-8-(trifluoromethyl)-

2H-1,5-Benzodiazepin-2-one, 1,3,4,5-tetrahydro-4,7-dimethyl-

2-Butenoic acid, 4-(3-chloro-4-methoxyphenyl)-4-oxo-, 2-chloroethylester, (2E)-

1,2-Ethanediaminium, N,N,N',N'-tetrakis(2-hydroxypropyl)-N,N'-dimethyl-, monoesters with coco fatty acids, dichlorides

2H-1,4-Benzodiazepin-2-one,1,3-dihydro-1-methyl-5-phenyl-3-(3-thienylmethylene)-, (E)-

d-Glucitol, 2-carboxyethyl ether, compds. with N,N-dimethylbenzenemethanamine

ETHANAMINIUM,2-AMINO-N-(2-AMINOETHYL)-N-(2-HYDROXYETHYL)-N-METHYL-,N,N-DI-C8-22-ACYL DERIVS.,CHLORIDES

2H-1,4-Benzoxazin-2-one,7-methoxy-3-[[1-oxo-7-(3-phenyl-1-propynyl)-2(1H)-isoquinolinyl]methyl]-

101809-52-3 msds

CAS No 101809-52-3 supplier

CASNo 101809-52-3 distributor

CAS # 101809-52-3 manufacturer

CAS Number 101809-52-3 safety

CAS RN 101809-52-3 wholesale

2026-10-13 DIPROPIONYLLISOSPIRAMYCIN,CAS No.101809-52-3,Formula:. Find Related Products for Bulk Production or Scientific Research